首页 | 本学科首页   官方微博 | 高级检索  
     

慢性阻塞性肺疾病的合并症/并发症的发病率和病死率分析
引用本文:陈华萍,甘志新,刘刚,刘双林,刘禹,焦玉丁,缪殿南,徐静,王关嵩,徐智,李琦,胡明冬.慢性阻塞性肺疾病的合并症/并发症的发病率和病死率分析[J].中华肺部疾病杂志(电子版),2021,14(4):417-421.
作者姓名:陈华萍  甘志新  刘刚  刘双林  刘禹  焦玉丁  缪殿南  徐静  王关嵩  徐智  李琦  胡明冬
作者单位:1. 400037 重庆,陆军(第三)军医大学第二附属医院老年与特勤医学科;400037 重庆,陆军(第三)军医大学第二附属医院呼吸与危重症医学中心2. 400037 重庆,陆军(第三)军医大学第二附属医院呼吸与危重症医学中心
基金项目:陆军军事医学创新工程专项(18CXZ002); 国家科技部重点研发计划项目(2016YFC130453)
摘    要:目的 探讨慢性阻塞性肺疾病(chronic obstructive pulmonary disease,COPD)的合并症/并发症的发病率和病死率.方法 选择我院呼吸与危重症医学中心2018年1月至2018年12月住院的COPD患者1210例,按照其合并症/并发症的类型进行分组,以单纯COPD为对照组,其余为病例组,观...

关 键 词:肺疾病  慢性阻塞性  合并症  并发症  发病率  病死率
收稿时间:2021-02-15

Study of morbidity and mortality in chronic obstructive pulmonary disease with co-morbidity and complications
Huaping Chen,Zhixin Gan,Gang Liu,Shuanglin Liu,Yu Liu,Yuding Jiao,Diannan Miao,Jing Xu,Guansong Wang,Zhi Xu,Qi Li,Mingdong Hu.Study of morbidity and mortality in chronic obstructive pulmonary disease with co-morbidity and complications[J].Chinese Journal of lung Disease(Electronic Edition),2021,14(4):417-421.
Authors:Huaping Chen  Zhixin Gan  Gang Liu  Shuanglin Liu  Yu Liu  Yuding Jiao  Diannan Miao  Jing Xu  Guansong Wang  Zhi Xu  Qi Li  Mingdong Hu
Affiliation:1. Department of Gerontology and Secret Service Medicine, the Second Affiliated Hospital of Army Medical University, Chongqing 400037, China; Department of Respiratory and Critical Care Medicine Center, the Second Affiliated Hospital of Army Medical University, Chongqing 400037, China2. Department of Respiratory and Critical Care Medicine Center, the Second Affiliated Hospital of Army Medical University, Chongqing 400037, China
Abstract:ObjectiveTo study the morbidity and mortality of co-morbidity and complications in patients with chronic obstructive pulmonary disease (COPD). Methods1 210 hospitalized patients with COPD were collected in Department of Respiratory and Critical Care Medicine Center from January 2018 to December 2018 in this study, and they were divided three groups, including COPD group, co-morbidity group and complication group. Meanwhile, the morbidity and mortality were observed, then, compared to different of the sex, age, course, smoking, the number of acute exacerbations per year, and mortality in the three groups. ResultsThe morbidity rate of co-morbidity/complications were 98.60%, and the mortality rate was 1.34%, which was significantly increasing than that of the control group(P<0.05). In the analysis of morbidity, the results indicated that the morbidity of cardiovascular diseases was significantly higher than other system disease, which was 36.37%. Secondly, the lung cancer was the highest in COPD with pulmonary disease, also 36.37%. Next, the respiratory failure was most rate in complications, was 20.95%. Otherwise, In the analysis of mortality, results shown that it was high mortality rate in COPD with cardiovascular system diseases, nervous system diseases, blood system diseases, respiratory failure, pulmonary encephalopathy, it was 4.25%, 4.28%, 5.00%, 3.60%, 6.25%. Moreover, there was markedly increasing in course and the number of acute exacerbations per year in co-morbidity/complications group compared to COPD group. Finally, In the analysis of morbidity and mortality in different classification, the result found that the morbidity of hypertension was highest, at 25.81%, however, the mortality of upper gastrointestinal hemorrhage was highest in all diseases, was 16.66%. ConclusionThe morbidity and mortality of COPD patients with complications are higher, which seriously influenced the treatment and prognosis of disease. Therefore, the co-morbidity and complications of COPD should be paid more attention in clinical work.
Keywords:Chronic obstructive pulmonary disease  Co-morbidity  Complications  Morbidity  Mortality  
本文献已被 CNKI 等数据库收录!
点击此处可从《中华肺部疾病杂志(电子版)》浏览原始摘要信息
点击此处可从《中华肺部疾病杂志(电子版)》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号